www.cellarity.comHealthcare / BioTech & PharmaFounded: 2017Funding to Date: $277MM
Cellarity is a biotech company focused on designing medicines against the cell as opposed to a single molecular target by leveraging a unique combination of expertise across system and network biology, high-resolution data, and machine learning to unlock treatments in a large number of therapeutic areas.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
10/04/2022 | Series C | $121MM | $xx.xx | $618.28MM | Flagship Pioneering, Kyowa Kirin, Hanwha Impact Partners | |
Price per Share
$xx.xx
Shares Outstanding
16,462,585
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
600.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Flagship Pioneering, Kyowa Kirin, Hanwha Impact Partners
|
||||||
02/25/2021 | Series B | $125.9MM | $xx.xx | $398.45MM | BlackRock, The Baupost Group, Bankque Pictet, Flagship Pioneering | |
Price per Share
$xx.xx
Shares Outstanding
20,983,333
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
600.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
BlackRock, The Baupost Group, Bankque Pictet, Flagship Pioneering
|
||||||
12/10/2019 | Series A-1 | $18.7MM | $xx.xx | $82.99MM | Flagship Pioneering | |
Price per Share
$xx.xx
Shares Outstanding
9,348,822
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Flagship Pioneering
|
||||||
12/10/2019 | Series A | $11.4MM | $xx.xx | $82.99MM | Flagship Pioneering | |
Price per Share
$xx.xx
Shares Outstanding
11,399,900
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Flagship Pioneering
|